Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

21.47
Delayed Data
As of 1:59pm ET
 -0.28 / -1.29%
Today’s Change
16.28
Today|||52-Week Range
33.30
+5.04%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close21.75
Today’s open21.76
Day’s range21.36 - 21.87
Volume69,427
Average volume (3 months)264,136
Market cap$760.8M
Dividend yield--
Data as of 1:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-117.05%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.82

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.22-1.81%
ACRSAclaris Therapeutics...-0.56-1.94%
HSKAHeska Corp-1.08-1.03%
CYTKCytokinetics Inc-0.75-4.41%
Data as of 2:13pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts